| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Degolyer Donald W serves as a Director at EBS. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $794K at current prices.
Historically, Degolyer Donald W's trades have earned a middling insider score of 54/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +0.7%.
The biggest single holding is EBS (~$794K) as Director. The recent filings there lean toward selling, a net 83,926 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | EBS Emergent Biosolutions Inc. | Director | Sell | 17,800 | $7.09 | $126,202.00 | -13.7% | - | - | |
| May 1, 2026 | EBS Emergent Biosolutions Inc. | Director | Sell | 15,481 | $8.40 | $129,993.56 | -10.7% | - | - | |
| Nov 10, 2025 | EBS Emergent Biosolutions Inc. | Director | Sell | 17,801 | $10.54 | $187,622.54 | -12.9% | +0.4% | - | |
| Aug 12, 2025 | EBS Emergent Biosolutions Inc. | Director | Sell | 7,844 | $8.65 | $67,830.99 | -5.4% | +23.3% | - | |
| Nov 12, 2024 | EBS Emergent Biosolutions Inc. | Director | Sell | 25,000 | $10.91 | $272,750.00 | -18.4% | -7.2% | -0.7% |